Uveal melanoma secondary prevention: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(7 intermediate revisions by 4 users not shown)
Line 3: Line 3:
{{CMG}}{{AE}}{{Simrat}}
{{CMG}}{{AE}}{{Simrat}}
==Overview==
==Overview==
Secondary prevention strategies following uveal melanoma include dilated [[fundus]] examination, [[liver function tests]], abdominal [[MRI]] and abdominal [[ultrasound]].  
There are no established measures for the [[secondary prevention]] of uveal melanoma.
==Secondary Prevention==
 
*There are no established measures for the [[secondary prevention]] of uveal melanoma.


==Secondary Prevention==
Currently, there is no consensus regarding type or frequency of scans following diagnosis and treatment of the primary eye tumor.  Approximately half of the patients with uveal melanoma will develop metastases within 15 years of initial diagnosis. Approximately 2% patients would show an evidence of metastasis at the time of initial uveal melanoma diagnosis. Of the 50% of patients who develop metastatic disease, more than 90% of patients will develop liver metastases. As such, the majority of surveillance techniques are focused on the liver. The surveillance techniques include regular dilated [[fundus]] examination, abdominal [[magnetic resonance imaging]] (MRI), abdominal [[ultrasound]] and [[liver function tests]]. These surveillance tests are performed every 6-12 months and can continue for many years.
== References ==  
== References ==  
{{reflist|2}}
{{reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Disease]]
[[Category:Disease]]
[[Category:Ophthalmology]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Ophthalmology]]
[[Category:Ophthalmology]]

Latest revision as of 18:12, 14 August 2019

Uveal melanoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Uveal melanoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Uveal melanoma secondary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Uveal melanoma secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Uveal melanoma secondary prevention

CDC on Uveal melanoma secondary prevention

Uveal melanoma secondary prevention in the news

Blogs on Uveal melanoma secondary prevention

to Hospitals Treating Uveal melanoma

Risk calculators and risk factors for Uveal melanoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

There are no established measures for the secondary prevention of uveal melanoma.

Secondary Prevention

References

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Uveal_melanoma_secondary_prevention&oldid=1579418"